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SIGNIFICANCE
Due to the growing importance of PNPLA1 mutations in the 
development of autosomal recessive congenital ichthyosis 
(ARCI), we decided to sequence this gene in a large, well-
characterized cohort of Spanish ARCI patients. The muta-
tional analysis revealed 7 different PNPLA1 mutations, 3 
of which were novel, in 13 individuals from 10 families. 
Interestingly, one of the identified mutations was present 
in 60% of the families (c.417_418delinsTC; p.Ser140Pro). 
Haplotype analysis of the c.417_418delinsTC carriers de-
monstrated that these families are descendants of a recent 
founder who lived in the XI century, implying that this re-
current mutation has founder effects in the Spanish popu-
lation.
Autosomal recessive congenital ichthyosis is a group 
of rare non-syndrome diseases that affect cornifica-
tion. PNPLA1 is one of the 12 related genes identified 
so far. Mutation screening of this gene has resulted 
in the identification of 13 individuals, from 10 fami-
lies, who carried 7 different PNPLA1 mutations. These 
mutations included 2 missense, 2 frame shift and 3 
nonsense, 3 of them being novel. One of the identified 
variants, c.417_418delinsTC, was highly prevalent, as 
it was found in 6 out of 10 (60%) of our autosomal 
recessive congenital ichthyosis families with PNPLA1 
mutations. Clinical manifestations varied significantly 
among patients, but altered sweating; erythema, pal-
mar hyperlinearity and small whitish scales in flexor-
extensor and facial areas were common symptoms. 
Haplotype analyses of c.417_418delinsTC carriers 
confirmed the existence of a common ancestor. This 
study expands the spectrum of the PNPLA1 disease, 
which causes variants and demonstrates that the 
c.417_418delinsTC mutation has founder effects in the 
Spanish population. 
Key words: ARCI; Spanish population; PNPLA1; founder 
effects; c.417_418delinsTC.
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Numerous hereditary cornification disorders that are clinically and aetiologically heterogeneous and 
follow a Mendelian inheritance pattern are grouped 
under the term of inherited ichthyosis. Autosomal re-
cessive congenital ichthyosis (ARCI) are a subgroup of 
non-syndrome ichthyosis, whose phenotypic spectrum 
ranges from harlequin ichthyosis (HI; OMIM 242500), 
to less severe phenotypes such as congenital ichthyosi-
form erythroderma (CIE; OMIM 242100) or lamellar 
ichthyosis (LI; OMIM 242300) the last two being the 
most common phenotypes. To date, 12 genes have 
been implicated in the development of ARCI: ABCA12, 
ALOX12B, ALOXE3, CYP4F22, NIPAL4, TGM1, LIPN 
and more recently CERS3, PNPLA1, CASP14, SDR9C7 
and SULT2B1 (1–3).
PNPLA1 is a gene that encodes a 58 kDa protein 
involved in the glycerophospholipid metabolism of the 
cutaneous barrier. Forty-seven disease causing muta-
tions have been described in PNPLA1 so far (4–12), 
the majority of which were reported within the last two 
years (4–9, 11, 12). Due to the growing importance 
of PNPLA1 mutations in the development of ARCI, 
we decided to screen for PNPLA1 defects in a large, 
well-characterized cohort of individuals with ARCI. 
Screening has resulted in the identification of a recur-
rent variant, c.417_418delinsTC, which was present 
in approximately half of our families. Given the high 
prevalence of this mutation among our Spanish patients, 
we tested the hypothesis that this mutation arose in a 
founder ancestor in the distant past.
Thus, the aims of this study are: (i) to report new cau-
sative PNPLA1 mutations in a Spanish cohort of patients 
with ARCI, (ii) to computationally assess the effect of 
the recurrent c.417_418delinsTC mutation on protein 
function, (iii) to evaluate whether families who carry 
this variant share a common ancestor and, if so, (iv) to 
estimate the time to their most recent common ancestor 
(TMRCA) and the age of the mutation.
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METHODS
Patients
A cohort of 91 Spanish patients (81 different families) with clini-
cal suspicion of ARCI was studied. A dermatologist clinically 
characterized all affected individuals. Clinical and genealogical 
information was collected for each family. Pedigrees and available 
clinical photos of the families are presented in Fig. 1 and Fig. S11. 
This study, carried out at FPGMX, was approved by the Galician 
Ethical Committee for Clinical Research (Code 2013/056) and 
the procedures followed were in accordance with the Declaration 
of Helsinki. All participants provided written informed consent.
Mutation analysis
The PNPLA1 gene was examined by Sanger sequencing or tar-
geted resequencing on SOLiD 5500xl or Ion Proton Platforms 
(Thermo Fisher Scientific; San Jose, CA, USA). Identified variants 
were confirmed in the proband and close relatives. The potential 
pathogenicity of each variant was assessed by using the Alamut® 
Visual 2.8.1 software (Interactive Biosoftware, Rouen, France).
Conserved Residue Analysis and Structural study of the 
c.417_418delinsTC mutation
The model published by Wilson et al. (13) was employed to 
represent the 3D human PNPLA patatin-like domain with the 
SWISS-MODEL tool (http://swissmodel.expasy.org). The effect 
of the mutation in the protein structure was evaluated with Swiss-
PdbViewer (http://spdbv.vital-it.ch). The degree of conservation 
of the Ser140 was evaluated using the Clustal Omega tool (http://
www.ebi.ac.uk/Tools/msa/clustalo).
Haplotype study
Haplotypes of c.417_418delinsTC mutation carriers, and 80 
Spanish healthy controls were reconstructed by genotyping 8 
microsatellite markers. These markers spanned a segment of 10Mb 
flanking the PNPLA1 gene locus. The age of the mutation was 
calculated with DMLE+ (http://www.dmle.org). The TMRCA was 
estimated by applying different linkage disequilibrium algorithms. 
Further details are available in Appendix S11.
RESULTS
Ten families, 8 new and 2 previously reported (5, 14, 
15), harboured 7 different PNPLA1 mutations. These 
families encompassed 8 patients with LI, 4 patients with 
CIE and one individual without any available phenotypic 
information. Patient´s clinical and genotypic data is pre-
sented in Table I. The 7 mutations included 2 missense, 
2 frameshift and 3 nonsense mutations. Three of the 7 
mutations identified were novel: c.282dup; p.(Lys95*), 
c.729C>G; p.(Tyr243*) and c.892C>T; p.(Arg298*). The 
4 known mutations comprised of 2 frameshift [c.1143del; 
p.(Pro382Alafs*74) and c.820del;p.(Arg274Glyfs*8)] 
previously described by Zimmer et al. (4) and Pichery 
et al. (6), respectively, and 2 missense [c.100G>A; 
p.(Ala34Thr) and c.417_418delinsTC; p.(Ser140Pro)] 
previously reported in a Spanish (13) and  French fa-
mily (4). Characteristics of the mutations found in the 
present study are described in detail in Table SI1. The 
most prevalent mutation, c.417_418delinsTC, was found 
in approximately half of the families (60%). Analysis 
of the protein structure showed that the Ser125 residue 
(structurally equivalent to Ser140 in PNPLA1) is present 
in a loop region, formed by the highly conserved residues 
(Fig. 2), indicating that the local environment of Ser140 
has probable structural consequences. 
Clinical manifestations varied significantly among 
patients, but altered sweating, erythema, palmar hyper-
linearity and small whitish scales that affected flexor 
and extensor surfaces and facial areas were common 
symptoms. However, prematurity and dark scales were 
infrequent. Ectropion, collodion at birth, palmoplantar 
keratoderma, alopecia and big scales were occasionally 
seen. Seven out of 12 patients were taking topical reti-
Fig. 1. Clinical photos of patients from families 23 (a–d), 62 (e–h) and 115 (i, j). a) Arms of the proband with generalized erythema and large 
adherent scales, b and c) back and hands of proband´s son with generalized erythema accompanied by fine white scales and palmar hyper linearity, 
respectively, d) proband´s daughter showing underlying erythroderma and generalized scaling, e) large whitish scales in legs with underlying erythema, f) 
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noids while the rest were treated with 
a combination of oral and topical 
retinoids (Table I).
A clear correlation between the 
location/type of mutation and the 
resulting phenotype was not found. 
According to the data in Table I, the 
combination of nonsense and mis-
sense mutations led to LI pheno types 
(Families 46, 98, 115), as well as 
frameshift and missense or homozy-
gous frameshift variants (Families 
62 and 137). The only carrier of a 
homozygous nonsense mutation 
showed CIE (Family 69). Patients 
with compound missense mutations 
had LI or CIE phenotypes indistinctly 
(Families 18, 23, 47, 119). 
Reconstructed haplotypes of 
c.417_418delinsTC carriers are 
presented in Table SII1. All carriers 
shared the same allele (7) for marker 
D6S439. A 4.1 Mb prevalent core 
haplo type (5–7–5) ranging from mar-
kers D6S497 to D6S1548 was identi-
fied. This core haplotype was found on 
4 out of 9 carrier chromosomes (44%) 
versus 18 out of 160 (11%) found on 
control chromosomes. To date the 
TMRCA of these 6 families, we used 
different algorithms, which resulted 
in different estimates. Averaging all 
these estimates would place the TM-
RCA approximately 38 generations 
ago (95% CI 29–46). However, the 
age of the c.417_418delinsTC, ranged 
from 103 to 108 generations, dating 
the first appearance of the mutation to 
approximately 2,575–2,700 years ago 
(assuming 25 years per generation). 
TMRCA and mutation age estimates 
are shown in Table SII1.
DISCUSSION
According to the localization of the 
reported PNPLA1 mutations, Zimmer 
et. al  (4) proposed a highly conserved, 
extended patatin domain that ranges 
from amino acid positions 1 to 288, 
increasing the size of the former 
functional region (Ile16-Thr185). 
Considering Zimmer’s proposal, 2 
of the 3 novel mutations described in 
this study, c.282dup; p.(Lys95*) and 
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within this extended domain in exons 2 and 5, respecti-
vely. These variants create truncated mRNAs that would 
most likely be degraded by the process of nonsense-med-
iated decay. Our third novel nonsense mutation in exon 
6, c.892C>T; p.(Arg298*), is the fifth variant reported, 
which is situated outside of the extended patatin domain 
(4, 5, 11). PNPLA1 protein contains a proline-rich domain 
(residues 326–451) in the C-terminal, which is conserved 
across species. Interestingly, all mutations located out-
side the extended patatin domain p.(Glu313Aspfs*49), 
p.(Pro370*), p.(Ser382Alafs*74), p.(Ala434Hisfs*10) 
and our novel variant p.(Arg298*) create premature stop 
codons before or within the proline-rich domain, with the 
exception of p.(Ser382Alafs*74). A schematic representa-
tion of PNPLA1, including novel and previously reported 
mutations, is shown in Fig. 3. 
The 3D model of the PNPLA patatin-like domain 
showed that the c.417_418delinsTC mutation, which 
involves the substitution of 2 nucleotides (GT>CT), 
alters a conserved serine residue located in a beta sheet 
hairpin loop (Fig. 2), which has an impact on the close 
hydrogen-bond interactions with other residues affecting 
the protein structure. 
The c.417_418delinsTC mutation has been described 
only in French and Spanish descents (4, 5). Due to the 
geographical proximity of these 2 countries, it is plausible 
that French and Spanish families share a common an-
cestor. The mutation could have arisen in Spain approx-
imately 2,625 years ago (VII century BC) and brought 
to France by a Spanish carrier or vice versa. 
To date, PNPLA1 mutations have been reported in 
different populations, French, Scandinavian, Iranian, 
Spanish, etc. (4, 10, 12, 14). The mutation frequency 
varies among the different populations, in Scandinavian 
countries mutations in PNPLA1 account for less than 1% 
of all ARCI-related mutations (10), whereas in highly 
consanguineous populations, such as Iran, the frequency 
reaches 15% (12). In our cohort, mutations in this gene 
represent 14% (13 out of 91) of the total ARCI cases. 
We propose that this unexpectedly high frequency of the 
mutated PNPLA1 could be due to the founder effect of 
the recurrent mutation, c.417_418delinsTC.
Fig. 3. Schematic representation of the 
PNPLA1 isoform 3 (NM_001145717) and 
the location of all mutations found to 
date including the novel reported in this 
study. The extended patatin-like domain of the 
gene is coloured in pink. The new mutations 
reported by this study are in bold letters while 
the founder Spanish mutation is underlined.
Fig. 2. Characteristics of the missense variant c.417_418delinsTC 
(p.Ser140Pro) in the PNPLA1 gene. (a) Comparison of partial amino acid sequence 
of human PNPLA1 across different species. Serine (S) within the red box indicates 
the conserved residue affected by the S140P mutation (b) nucleotide sequence in 
a homozygous affected member in the upper panel, a heterozygous carrier in the 
middle panel and wild type sequence in the lower panel, c) 3D-dimensional structure 
of the patatin domain indicating beta sheets in yellow, alpha helices in green, wild 
type Ser 125 and mutant Pro 125 in green colour, Arg151 in yellow and Phe 123 in 
orange. Green dots represent a strong H-bond while purple dots represent a clash 
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In conclusion, this study reports 3 novel mutations 
expanding the spectrum of the PNPLA1 disease causing 
variants and posits the possible mechanism underlying 
the pathogenicity of the c.417_418delinsTC mutation. 
Furthermore, we demonstrate that this mutation has 
founder effects in the Spanish population. TMRCA 
estimations suggest that carrier families could have 
descended from a single recent founder who lived in 
Spain during the XI century, while the mutation arose 
about 1,700 years prior.
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